Center-Authored Papers

Filters: Author is Lam, Hung-Ming  [Clear All Filters]
2015
Ruppender N, Larson S, Lakely B, Kollath L, Brown L, Coleman I, Coleman R, Nguyen H, Nelson PS, Corey E et al..  2015.  Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy.. PloS one. 10(6):e0130565. Abstract
Haider M, Zhang X, Coleman I, Ericson N, True LD, Lam H-M, Brown LG, Ketchanji M, Nghiem B, Lakely B et al..  2015.  Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases.. Clinical & experimental metastasis. Abstract
Zhang X, Coleman I, Brown LG, True LD, Kollath L, Lucas JM, Lam H-M, Dumpit R, Corey E, Chéry L et al..  2015.  SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
2016
Lam H-M, McMullin R, Nguyen H, Coleman I, Gormley M, Gulati R, Brown L, Holt S, Li W, Ricci DS et al..  2016.  Characterization of an abiraterone ultraresponsive phenotype in castration-resistant prostate cancer patient-derived xenografts.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Schade GR, Holt S, Zhang X, Song D, Wright JL, Zhao S, Kolb S, Lam H-M, Levin L, Leung Y-K et al..  2016.  Prostate cancer expression profiles of cytoplasmic ERβ1 and nuclear ERβ2 are associated with poor outcomes following radical prostatectomy.. The Journal of urology. Abstract
Roudier MP, Winters BR, Coleman I, Lam H-M, Zhang X, Coleman R, Chéry L, True LD, Higano CS, Montgomery B et al..  2016.  Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer.. The Prostate. 76(9):810-22. Abstract
2017
Nguyen HM, Vessella RL, Morrissey C, Brown LG, Coleman IM, Higano CS, Mostaghel EA, Zhang X, True LD, Lam H-M et al..  2017.  LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer Therapeutics.. The Prostate. Abstract